Cargando…
Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox
Use of oral antifungals in the treatment of onychomycosis is commonplace; but their use can be limited by safety and patient concerns. Due to their broader safety margins, topical antifungals (efinaconazole, tavaborole, and ciclopirox) are a useful option in the treatment of mild-to-moderate onychom...
Autores principales: | Tachibana, Haruki, Kumagai, Naomichi, Tatsumi, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753160/ https://www.ncbi.nlm.nih.gov/pubmed/29371574 http://dx.doi.org/10.3390/jof3040058 |
Ejemplares similares
-
Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum
por: Monti, Daniela, et al.
Publicado: (2019) -
Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success
por: Pollak, Richard A., et al.
Publicado: (2015) -
Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole
por: Masumoto, Akane, et al.
Publicado: (2022) -
Spotlight on tavaborole for the treatment of onychomycosis
por: Jinna, Sphoorthi, et al.
Publicado: (2015) -
An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015)